+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America

  • ID: 4040535
  • Report
  • Region: North America, Canada, United States
  • 49 Pages
  • Renub Research
1 of 3
It is Estimated that Over 4,000 Women in the United States and 400 Women in Canada Have Died from Cervical Cancer in 2016

Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America report provides a comprehensive analysis and forecast till 2020. This report provides a complete analysis of 2 Countries Cervical Cancer Test Market & Number of Cervical Cancer Population.

Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most preventable types of cancer.

Pap smear and HPV DNA test are two most popular testing methods to diagnose cervical cancer cases in North America. United States is the leader in North America cervical cancer test market. It holds over 90 percent testing population share alone, and is likely to maintain its position in forecasting period as well due to women getting regular Pap tests.

The 2 countries in this report have been studied from 3 viewpoints.

North America Cervical Cancer Test Market, Volume & Mortality:

  • Cervical cancer Test Population (2008-2020)
    • Pap smear test population (2008-2020)
    • HPV DNA test population (2008-2020)
  • Cervical Cancer Mortality Population (2001-2011)
  • Cervical Cancer Test Market (2008-2020)
    • Pap smear test market (2008-2020)
    • HPV DNA test market (2008-2020)

Countries studied in the report are as follows:

  • United States
  • Canada

Data Sources:

  • This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by industry experts.
  • Primary sources include industry surveys and telephone interviews with industry experts.
  • Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

Note: This report offers 10% free customization.
Note: Product cover images may vary from those shown
2 of 3

1. Executive Summary

2. North America Cervical Cancer Test (Screening) Population & Forecast

3. North America Cervical Cancer Test (Screening) Market & Forecast
3.1 North America Cervical Cancer Pap Smear Test (Screening) Market & Forecast
3.2 North America Cervical Cancer HPV DNA Test (Screening) Market & Forecast

4. North America Cervical Cancer Test (Screening) Population Share, Market Share & Forecast
4.1 North America Cervical Cancer Test (Screening) Population Share & Forecast
4.2 North America Cervical Cancer Test (Screening) Market Share & Forecast
4.3 North America Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
4.4 North America Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast

5. United States - Cervical Cancer Test Analysis
5.1 United States Cervical Cancer Test (Screening) Population
5.1.1 United States Cervical Cancer Pap Smear Test Population & Forecast
5.1.2 United States Cervical Cancer HPV DNA Test Population & Forecast
5.2 United States Cervical Cancer Mortality
5.3 United States Cervical Cancer Test (Screening) Market
5.3.1 United States Cervical Cancer Test Market & Forecast
5.3.2 United States Pap smear Test Market & Forecast
5.3.3 United States HPV DNA Test Market & Forecast

6. Canada - Cervical Cancer Test Analysis
6.1 Canada Cervical Cancer Test (Screening) Population
6.1.1 Canada Cervical Cancer Pap Smear Test Population & Forecast
6.1.2 Canada Cervical Cancer HPV DNA Test Population & Forecast
6.2 Canada Cervical Cancer Mortality
6.3 Canada Cervical Cancer Test (Screening) Market
6.3.1 Canada Cervical Cancer Test Market & Forecast
6.3.2 Canada Pap Smear Test Market & Forecast
6.3.3 Canada HPV DNA Test Market & Forecast

7. Cervical Cancer Test Market Growth Drivers
7.1 Worldwide Rising Incidence of Teenage Sexual Cases
7.2 Worldwide High Prevalence of HPV Infected Patients

8. Challenges in Cervical Cancer Test Market
8.1 Increase HPV Vaccination

List of Figures
Figure 2 1: North America - Cervical Cancer Test Population (Million), 2008 - 2015
Figure 2 2: North America - Forecast for Cervical Cancer Test Population (Million), 2016 - 2020
Figure 3 1: North America - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 3 2: North America - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 3 3: North America - Cervical Cancer Pap Smear Test Market (Million US$), 2008 - 2015
Figure 3 4: North America - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 - 2020
Figure 3 5: North America - Cervical Cancer HPV DNA Test Market (Million US$), 2008 - 2015
Figure 3 6: North America - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 - 2020
Figure 4 1: North America - Cervical Cancer Test Population Share (Percent), 2008 - 2015
Figure 4 2: North America - Forecast for Cervical Cancer Test Population Share (Percent), 2016 - 2020
Figure 4 3: North America - Cervical Cancer Test Market Share (Percent), 2008 - 2015
Figure 4 4: North America - Forecast for Cervical Cancer Test Market Share (Percent), 2016 - 2020
Figure 4 5: North America - Cervical Cancer Pap Smear Test Market Share (Percent), 2008 - 2015
Figure 4 6: North America - Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 - 2020
Figure 4 7: North America - Cervical Cancer HPV DNA Test Market Share (Percent), 2008 - 2015
Figure 4 8: North America - Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 - 2020
Figure 5 1: United States - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 5 2: United States - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 5 3: United States - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 5 4: United States - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 5 5: United States - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 5 6: United States - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 5 7: United States - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 5 8: United States - Pap smear Test Market (Million US$), 2008 - 2015
Figure 5 9: United States - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 5 10: United States - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 5 11: United States - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 6 1: Canada - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 6 2: Canada - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 6 3: Canada - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 6 4: Canada - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 6 5: Canada - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 6 6: Canada - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 6 7: Canada - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 6 8: Canada - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 6 9: Canada - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 6 10: Canada - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 6 11: Canada - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020

List of Tables
Table 7 1: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006
Table 7 2: Worldwide - Prevalence of HPV 16/18 in Women with Normal Cervical Cytology (Percent), 2014 - 2015

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll